Brazil scraps Covaxin's EUA application after Bharat Biotech terminates pact with partners
The Hindu
This comes in the backdrop of Brazil suspending the proposed clinical trials of Covaxin
After suspending the proposed clinical trials of Bharat Bioetch’s COVID-19 vaccine Covaxin, Brazil has now scrapped the Emergency Use Authorisation (EUA) request made by the Indian company for the jab. The Brazilian health regulator's decision comes after the vaccine maker informed the South American country about the termination of its pact with its partners in that country. According to a statement issued by the National Health Surveillance Agency of Brazil, Anvisa, its Collegiate Board on July 24 unanimously decided "to close the process that dealt with the temporary authorization of emergency use, on an experimental basis, of the Covaxin vaccine".More Related News

Through perseverance, and even a form of doughtiness, Stella Maris college has made it to number two on eBird’s checklists leaders’ roll for Chennai in 2025. On December 27, around 2.15 p.m., when this edition was rushing with winged feet to the press, Stella Maris campus stood with 442 checklists for 2025, with only Adayaru Esturary ahead of it with 451 checklists.












